11.04.26 -- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter

Stop losing time and capacity to manual paperwork. Learn how digital workflows eliminate compliance risks and unlock the actionable data needed to optimize life sciences manufacturing.

Discover how automating sterile fluid transfers removes human contamination risks, solves operator shortages, and reduces cell therapy manufacturing costs by up to 74%.

Ensure cleanroom compliance by aligning disinfectant validation with real-world application methods. Watch for a deeper look into navigating the complex regulatory expectations and optimizing your CCS.

Compare Nebulized Hydrogen Peroxide (NHP) and Vaporized Hydrogen Peroxide (VHP) efficacy, cycle times, and validation challenges inside pharmaceutical isolators to optimize your aseptic processing turnaround.

Improve workflow coordination across lab systems with better visibility, automated decision logic, audit-ready traceability, and repeatable processes that help teams move work more efficiently.

See how specialized aseptic bag filling technologies maintain uncompromised process reliability and full regulatory compliance for complex pharmaceutical products.

Uncover how integrated, data-driven solutions can help you reduce downtime, improve visibility, and streamline compliance across your manufacturing operations.

EU GMP Annex 1 now defines clear expectations for glove integrity testing. Examine how reliability, efficiency, and equipment usability are becoming essential factors for maintaining compliance.

A fire in a pharmaceutical cleanroom can be contained, but for sterile manufacturers, smoke can turn a localized event into a far wider decontamination, requalification, and production-recovery challenge.

Recent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.

Scaling cell therapy requires a new approach to quality control. Explore how integrated systems, improved data flow, advanced analytics, and thoughtful automation can support faster decisions.

Understand new insights about stability testing, how it impacts manufacturing, distribution, and supply chains, and how to build a stronger program in this analysis of recent FDA Complete Response Letters (CRLs).

An Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.